Skip to main content
MedChemComm logoLink to MedChemComm
. 2018 Mar 7;9(3):593–594. doi: 10.1039/c8md90012d

Correction: Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

Hui Li Heng a, Chin Fei Chee a,b, Sek Peng Chin a,b, Yifan Ouyang c, Hao Wang c, Michael J C Buckle a,, Deron R Herr d, Ian C Paterson e, Stephen W Doughty f, Noorsaadah Abd Rahman b, Lip Yong Chung a,
PMCID: PMC6144813  PMID: 30288212

Abstract

Correction for ‘Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists’ by Hui Li Heng et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00629b.

The authors regret that Scheme 1 showed the wrong structure for 12a, 12b, 3a and 3b. Please find below the corrected scheme.

Scheme 1.

Scheme 1

In addition, there were some errors in the numbering of two of the amino acids in Fig. 4, panels C and D. Please find below the corrected figure, including corrected caption.

Fig. 4. The docking poses of the two enantiomers of roemerine in complex with the 5-HT2A and 5-HT2C receptors. A and C. The poses of (R)-roemerine enable a π–π interaction with Phe340/328 as depicted by the black dotted lines. B and D. The poses of (S)-roemerine do not allow a π–π interaction with Phe340/328. For the purpose of clarity, only the principal binding residues are depicted and some of the transmembrane helices are not shown.

Fig. 4

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Articles from MedChemComm are provided here courtesy of Royal Society of Chemistry

RESOURCES